Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

EEO. 2022; 21(2): 164-173


The Effectiveness Of Compassion Therapy On Self-Efficacy And Pain Control In Patients With Ms

Sahra Naseri, Alireza Ghanipour, Elika GhaviPanjeh, Mozhgan Jamshidi Eyni, Amir Mohammad Amiri.




Abstract

Background and Aim: MS is an inflammatory disease of the central nervous system characterized by demyelination of the myelin sheath of axons and leads to defects or limitations in the transmission of nerve impulses. The aim of the present study was to evaluate the effectiveness of compassion therapy on self-efficacy and pain control in patients with MS.
Methods: The present study is applied in terms of purpose and semi-experimental in terms of method with pre-test and post-test design with control group. The statistical population of this study included all people with multiple sclerosis (MS) who referred to medical centers in Tehran in 1400. 30 people were selected from the study population by available sampling method and randomly assigned to experimental and control groups (15 people). they got. The experimental group was trained in 12 sessions of 90 minutes with compassion therapy. Subjects completed the Sherer et al. Self-efficacy questionnaire and the pain management questionnaire (Rosenstein & Kyiv, 1983) before and after treatment. In order to analyze the data of this study, SPSS software version 21 and descriptive statistics and inferential statistics and analysis of covariance were used.
Results: The results of analysis of covariance confirm the effect of compassion therapy on increasing self-efficacy and pain control in patients with multiple sclerosis (p

Key words: Compassion Therapy, Self-Efficacy, Pain Control, MS






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.